These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21255527)

  • 1. A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers.
    Lal R; Sukbuntherng J; Ho J; Cundy KC
    Int J Clin Pharmacol Ther; 2011 Feb; 49(2):109-15. PubMed ID: 21255527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
    Chen C; Upward J; Arumugham T; Stier B; Davy M
    Clin Ther; 2015 Feb; 37(2):349-57. PubMed ID: 25467190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
    Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
    Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Huff FJ; Zou J; Cundy KC
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):120-8. PubMed ID: 20137764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Tovera J; Lassauzet ML; Cundy KC
    J Clin Pharmacol; 2013 Jan; 53(1):29-40. PubMed ID: 23400741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
    Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Davy M; Upward J; Arumugham T; Twomey C; Chen C; Stier B
    Clin Ther; 2013 Dec; 35(12):1964-74. PubMed ID: 24290737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Chen D; Lal R; Zomorodi K; Atluri H; Ho J; Luo W; Tovera J; Bonzo D; Cundy K
    Clin Ther; 2012 Feb; 34(2):351-362.e3. PubMed ID: 22325733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin enacarbil in restless legs syndrome.
    Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
    Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
    Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin enacarbil: in patients with restless legs syndrome.
    Scott LJ
    CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy.
    Rauck R; Makumi CW; Schwartz S; Graff O; Meno-Tetang G; Bell CF; Kavanagh ST; McClung CL
    Pain Pract; 2013 Jul; 13(6):485-96. PubMed ID: 23186035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass balance study of [14C] rabeprazole following oral administration in healthy subjects.
    Setoyama T; Drijfhout WJ; van de Merbel NC; Humphries TJ; Hasegawa J
    Int J Clin Pharmacol Ther; 2006 Nov; 44(11):557-65. PubMed ID: 17176622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.
    Lal R; Sukbuntherng J; Luo W; Vicente V; Blumenthal R; Ho J; Cundy KC
    Br J Clin Pharmacol; 2010 May; 69(5):498-507. PubMed ID: 20573085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
    Bogan RK; Bornemann MA; Kushida CA; Trân PV; Barrett RW;
    Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
    Burke RA; Faulkner MA
    Expert Opin Pharmacother; 2011 Dec; 12(18):2905-14. PubMed ID: 22077768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.